Prevalence of Toxoplasma Gondii and Toxocara Canis Among Patients With Uveitis
Investigate the prevalence of Toxoplasma gondii and Toxocara canis in Uveitis
- serum antibody to T. gondii and T. canis
- PCR with peripheral blood for T. gondii and T. canis
- PCR with aqueous humor for T. gondii and T. canis
- Clinical manifestation of patient with uveitis
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Consecutive patients with uveitis are enrolled in Nune Eye Hospital.
Serum ELISA
- IgM,IgG antibody to Toxoplasma gondii
- IgG antibody to Toxocara canis
PCR
- PCR with serum and aqueous humor to Toxoplasma gondii
- PCR with serum and aqueous humor to Toxocara canis Clinical characteristics
- visual acuity
- intraocular pressure (IOP)
- location and degree of inflammation
- other fundus findings were recorded
questionnaire
- environment, occupation
- pet ownership, exposure to animal
- history of eating raw liver of animal, raw beef or any other raw flesh of animal.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients with uveitis
Exclusion Criteria:
- Patients with history of major ophthalmic surgery within 6 months
- antiviral, antifungal or antiparasitic therapy within 6 months
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patients with positive result for serum antibody to Toxoplasma gondii and Toxocara canis
Time Frame: at baseline
|
proportion of patients with seropositive for Toxoplasma gondii and Toxocara canis among patients
|
at baseline
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patients with positive PCR with peripheral blood and aqueous humor to Toxoplasma gondii and Toxocara canis
Time Frame: at baseline
|
Proportion of patient with positive PCR to Toxoplasma gondii and Toxocara canis
|
at baseline
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
location of inflammation and fundus finding
Time Frame: at baseline
|
location of inflammation
fundus finding
|
at baseline
|
|
Demographic characteristics
Time Frame: at baseline
|
|
at baseline
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Su Jin Lim, MD, Nune Eye Hospital
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Nuneuveitis
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.